Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Sunshine Noah: BTP4327 Clinical Trial Application Approved
Sunshine Nuohuo Announcement: The company and its subsidiary, Jiangsu Nuohuo Becton New Drug Research and Development Co., Ltd., have received the “Drug Clinical Trial Approval Notice” issued by the National Medical Products Administration. The clinical trial application for the company’s ongoing project BTP4327 has been approved. BTP4327 is a Class 2 chemical drug, an improved new drug, intended to treat hypertension by lowering blood pressure. It is for patients whose blood pressure cannot be adequately controlled with monotherapy.